Immunohistochemical expression of SKALP/elafin in squamous cell carcinoma of the oesophagus
1997

Expression of SKALP/elafin in Oesophageal Cancer

Sample size: 34 publication Evidence: moderate

Author Information

Author(s): S Yamamoto, H Egami, T Kurizaki, H Ohmachi, N Hayashi, T Okino, Y Shibata, J Schalkwijk, M Ogawa

Primary Institution: Kumamoto University Medical School

Hypothesis

The study investigates the expression of SKALP/elafin in squamous cell carcinoma of the oesophagus and its relationship with tumor differentiation.

Conclusion

The expression of SKALP/elafin is significantly related to the differentiation of squamous cell carcinoma of the oesophagus.

Supporting Evidence

  • SKALP/elafin expression was localized in the cells of the stratified zone adjacent to PCNA-positive basal cells in non-malignant oesophageal mucosa.
  • 73.5% of oesophageal carcinomas showed immunoreactivity with anti-SKALP/elafin serum.
  • The expression of SKALP/elafin was found in all well-differentiated squamous cell carcinoma specimens.
  • Undifferentiated carcinoma cells did not express SKALP/elafin at all.

Takeaway

This study looked at a protein called SKALP/elafin in cancer cells of the esophagus and found that it is more common in better-differentiated tumors.

Methodology

Immunohistochemical staining was performed on tissue samples from oesophageal carcinoma and non-malignant mucosa to evaluate SKALP/elafin expression.

Limitations

The study did not find a relationship between SKALP/elafin expression and other clinicopathological factors such as depth of invasion and lymph node metastasis.

Participant Demographics

The study included 34 patients, consisting of 30 men and 4 women, with an average age of 64.1 years.

Statistical Information

P-Value

0.010

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication